GSTM1 and hemoglobinopathy: The first report of Hb Q-Iran and the nomenclature of this hemoglobinopathy dates back to 1970 and the work of Lorkin et al., introducing the substitution of aspartic acid by histidine at position α75 (EF4) as the responsible defect for this hemoglobinopathy [5].